TPG GP A’s Satsuma Pharmaceuticals STSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-1,885,939
Closed -$11.3M – 40
2022
Q3
$11.3M Hold
1,885,939
– – 0.19% 33
2022
Q2
$7.81M Hold
1,885,939
– – 0.12% 34
2022
Q1
$7.17M Hold
1,885,939
– – 0.09% 37
2021
Q4
$8.49M Buy
+1,885,939
New +$9.6M 0.08% 38

Other funds holding STSA

TPG GP A's STSA Position: Q4 2022 in Review

TPG GP A sold out of Satsuma Pharmaceuticals (STSA) in Q4 2022, closing a stake of 1,885,939 shares — an estimated $11.3M sold.

TPG GP A first reported a position in STSA in Q4 2021 and held it in 4 quarters. The position peaked at $11.3M in Q3 2022. 32 funds tracked by Wall St. Rank hold STSA as of Q4 2022.

  • TPG GP A reported no remaining Satsuma Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • TPG GP A sold 1,885,939 Satsuma Pharmaceuticals shares in Q4 2022, an estimated $11.3M.
  • TPG GP A first reported a position in Satsuma Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • TPG GP A's Satsuma Pharmaceuticals position peaked at $11.3M in Q3 2022.
  • 32 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals as of Q4 2022.

Based on TPG GP A's 13F filing for Q4 2022, filed 14 Feb 2023.